Who or what has done the most damage to pharma this year? Some might say Bass. IMHO, it might have been Martin Shkreli, the Turing CEO. By buying rights to an old off patent drug and then jacking the price up enormously, he has focused attention on pharma and prompted both politicians and media to condemn the "outrageous behavior" of the pharma industry.
Wikipedia provides an outline of his business career here. https://en.wikipedia.org/wiki/Martin_Shkreli
His experience prior to Turing seems mainly to have been in the hedge fund business where he challenged both a new diagnostic drug and an inhalable insulin therapy while publicly shorting the manufacturers' stocks. Similar to but different from Bass.
Again, according to Wikipedia, he resigned from Retrophin after the board decided to replace him as CEO and, according to Wikipedia, has been under criminal investigation since early this year for Retrophin activities.
Is it possible that this sophisticated young hedge fund manager set about to discredit pharma so he could again short industry stocks through his actions at Turing? If so, implausible as it might seem, he has been successful.